Laparoscopic Staging of Periampullary Neoplasms
Executive Summary
Preoperative staging laparoscopy is a critical diagnostic tool used to refine the selection of candidates for the operative resection of periampullary neoplasms. Its primary clinical value lies in identifying patients with unresectable disease, thereby preventing unnecessary celiotomies (open surgical explorations) that offer no therapeutic benefit and subject patients to avoidable postoperative recuperation.
Key takeaways include:
Target Population: Specifically indicated for pancreatic adenocarcinoma (head lesions >3 cm or CA 19-9 >150 U/mL; all body/tail lesions), distal bile duct cancer, and duodenal cancer.
Procedural Efficacy: It allows for the identification of small metastases and the assessment of locally advanced disease that may be missed by standard radiologic imaging.
Operational Standards: The procedure requires a systematic, multiport approach, often augmented by laparoscopic ultrasonography to evaluate vascular involvement and tumor relationships.
Patient Outcomes: Designed as an outpatient procedure, it facilitates high-quality staging with minimal recovery time, allowing incurable patients to proceed directly to nonoperative palliation.
Indications and Patient Selection
The global objective of staging is to distinguish between candidates for curative resection and those requiring palliation.
Clinical Indications
Pancreatic Adenocarcinoma:
Head lesions larger than 3 cm.
Any head lesion where CA 19-9 is higher than 150 U/mL.
All lesions located in the pancreatic body and tail.
Other Malignancies: Distal bile duct cancer and duodenal cancer.
Advanced Staging: Evaluating locally advanced disease prior to initiating chemoradiation.
Diagnostic Confirmation: Suspected metastatic disease or histologic confirmation of disease deemed unresectable by radiology.
Contraindications
Absolute: Patients unfit for general anesthesia, intra-abdominal sepsis, and coagulopathy.
Relative: Multiple previous upper abdominal operations.
Preoperative Investigation and Preparation
Diagnostic Workup
Before the procedure, a comprehensive evaluation is required to establish a baseline:
Clinical: Assessment for jaundice, weight loss, cachexia, epigastric masses, and ascites.
Laboratory: Liver function tests (albumin, protein, bilirubin, etc.), coagulation parameters (PT, APTT), electrolytes, full blood count, C-reactive protein, and tumor markers (CA 19-9, CEA).
Imaging: Ultrasonography; contrast-enhanced, dynamic, thin-cut CT; EUS; ERCP; and MRCP.
Equipment and Instrumentation
The procedure utilizes a multiport technique requiring specific laparoscopic tools:
Surgical Methodology and Systematic Examination
Patient Positioning and Access
Position: Supine on the operating table with a warming blanket.
Anesthesia: General anesthesia is mandatory; an orogastric tube is used for stomach decompression.
Initial Access: A 10-mm blunt port (Hassan-type) is placed via open cutdown in the infraumbilical area.
Pneumoperitoneum: Established with CO2 at an optimal pressure of 10 to 12 mm Hg.
Secondary Ports: If no obvious metastases are visible upon initial inspection, additional ports are placed in the right upper quadrant (10 mm and 5 mm) and left upper quadrant (5 mm).
The Systematic Examination Sequence
A thorough exploration must mimic an open surgical approach, following a specific sequence:
Peritoneal Cavity: General inspection for peritoneum-based masses (biopsied if found).
Liver: Tilt the patient 10 degrees head up. Examine the anterior and posterior aspects of the left lateral lobe (segments 2 and 3), followed by the right hepatic lobe.
Hilus and Foramen of Winslow: Elevate the right liver lobe to inspect the hepatoduodenal ligament and suspicious nodes.
Ligament of Treitz: Tilt the patient 10 degrees head down; retract the omentum and transverse colon to inspect the colonic mesocolon.
Lesser Sac and Pancreas: With the patient supine, incise the gastrohepatic omentum (preserving any aberrant left hepatic artery) to examine the neck and body of the pancreas and nodes along the left gastric or hepatic arteries.
Laparoscopic Ultrasonography
Laparoscopic ultrasonography is a critical adjunct for determining resectability. The probe is inserted through the lateral 10-mm port in the right upper quadrant.
Liver Scanning: Systematic review of segments I, II, and III, followed by the right lobe.
Vascular Assessment: Identification of the common hepatic duct, bile duct, portal vein, and hepatic arteries using color flow Doppler.
Tumor Evaluation: Determination of the relationship between the tumor and the pancreatic duct, as well as peripancreatic vessels (portal vein, superior mesenteric vein, and superior mesenteric artery).
Postoperative Considerations and Clinical Best Practices
Postoperative Care
The procedure is typically performed on an outpatient basis.
Standard monitoring for post-laparoscopy issues (e.g., shoulder pain, trocar site infection, or hernia).
Warning Signs: Severe pain or fever are abnormal and require aggressive evaluation to rule out inadvertent injury to abdominal viscera.
Surgical "Tricks" for Optimization
Deliberate Pace: Move slowly; metastases are often small and easily overlooked.
Hemostasis: Maintain absolute hemostasis, as blood absorbs light and obscures critical anatomy.
Multiple Ports: A single-port examination is insufficient for appropriate exposure.
Port Placement: Positioning the 10-mm port as lateral as possible in the right upper quadrant allows the ultrasound probe to sit at a right angle over the hepatoduodenal ligament, facilitating better visualization of ducts and vessels.
Anatomy: Mobilization of the duodenum is not required for successful staging.
